Avid Bioservices Net Income

Avid Bioservices (CDMO) currently reports a net income of $-150M as of October 2024. That compares with $-11M in the prior-year period — down 1227.9% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Avid Bioservices's net income history and peer comparisons.

Avid Bioservices's net income decreased from $-11M to $-150M — a 1227.9% year-over-year decrease (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices's net income of $-150M is lower than the Healthcare sector average of $16B. That is roughly 100.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Avid Bioservices reported $-150M in net income as of October 2024. That compares with $-11M in the prior-year period — down 1227.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-150M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.